Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical . On average, Hafrun trades about 17,642 units every 30 days since 2012. Location 60 Columbia Road, Morristown, New jersey, United States Get Access to Hafrun's Email Address & Phone Number Additional Contacts at Actavis U.S. Michael Bryner Vice President, Intellectual Property and Patent Counsel mi*******@actavis.com +1******27 Hafrun Fridriksdottir Vice President R and D ha*******@actavis.com +1******00 Deborah null To: Hafrun Fridriksdottir . . As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. Search or verify contact lists in minutes with bulk tasks. Hafrun Fridriksdottir is Executive Vice President and Presidentident of Global Generics R&D of TEVA PHARMACEUTICAL. From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,056 and over the last 10 years he sold TEVA stock worth over $2,489,961. the retention bonus available to employee is $300,000.00 (subject to section 9 (e) below and all other applicable deductions), which shall be paid 50% in march of 2018 and 50% in march of 2019 on the same day as payments under the teva bonus plan are paid, the ("payment dates"), provided employee remains a teva employee in good standing through County Dublin, Ireland Sales Assistant . There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. The most active insiders traders include Sol J Barer, Tal Zvi Zaks y Kare Schultz. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries . The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Report this profile Experience Customer Support Representative Concentrix Sep 2018 - Present 3 years 8 months. 50,860 units of TEVA stock worth $506,006 on 10 Aug 2021. The estimated Net Worth of Hafrun Fridriksdottir is at least $6.88 Million dollars as of 17 May 2022. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. Build highly targeted prospect lists. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries stock worth over $9,550 and over the last 10 years he sold TEVA stock worth over $2,489,961. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 worth over $1,068,600. As the VP of Teva Pharmaceutical Industries Limited, Dr. Fridriksdottir earned a total compensation package of $4,290,333.00 in 2020. This amount will be paid according to the originally planned vesting schedule: 50% at . Hafrun Fridriksdottir's largest sale order was 130,000 units , worth over $1.07M on May 19, 2022. Dr. Hafrun Fridriksdottir is 60 years old, born in 1962. Dr. Hafrun Fridriksdottir has made 18 insider trades between 2018-2021, according to the Form 4 filled with the SEC. $9,160,000 in Teva Pharmaceutical Industries Limited. From 1997 to 2002, Dr. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. Enrich your list with 50+ firmographic fields. The most active insiders traders include Sol J Barer, Tal Zvi Zaks und Kare Schultz. Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc. Exhibit 10.34 . Teva Pharmaceutical Industries Limited executives and other stock owners filed with the SEC: Strike the best investing opportunities on the market! Dr. Fridriksdottir earned a salary of $720,000.00, a bonus of $562,500.00, stock awards of $1,999,987.00, non-equity compensation of $828,576.00, and other compensation of $179,270.00. . Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. You can see the complete history of Hafrun Fridriksdottir stock trades at the bottom of the page. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. The estimated net worth of Dr. Hafrun Fridriksdottir is at least $10,878,289 as of 10 Aug 2021. Chrome Extension. Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. Its products in the central nervous system include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries stock worth over $1,058,612 and over the last 9 years he sold TEVA stock worth over $1,421,361. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Teva Pharmaceutical Industries Limited has a collaboration MedinCell for the development and commercialization of multiple long-acting injectable products, a risperidone suspension for the treatment of patients with schizophrenia. Age : 59. July 01, 2022. November 27, 2017 by Chain Drug Review Brendan O'Grady, Dipankar Bhattacharjee, . There are 11 older and 16 younger executives at Teva- Pharmaceutical Industries. From 1997 to 2002, Dr. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. The most active insiders traders include Sol J Barer, Tal Zvi Zaks s Kare Schultz. From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016. As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. Bulks. as Executive Vice President of Global R&D in Teva Pharmaceutical Industries Limited. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. You can see the complete history of Hafrun Fridriksdottir stock trades at the bottom of the page. Hafrun Fridriksdottir Net Worth. Hafrun Fridriksdottir corporate profile, background and performance evaluation including other TEVA PHARMACEUTICAL executives The most recent stock trade was executed by Tal Zvi Zaks on 4 November 2022, trading 12,205 units of TEVA stock currently worth $114,971. View Hafrun Fridriksdottir's profile for company associations, background information, and partnerships. From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016. Hafrun Fridriksdottir's Trading History Company Name Last Transaction Date Insider Position Last Transaction Last Transaction Amount Holding Value TEVA Teva Pharmaceutical May 19, 2022 Executive VP, Global R&D Informative Sell $1.07M $12.21K It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. Dr. Hafrun Fridriksdottir salary is $2,290,000 per year Most recently he exercised 94,157 units of TEVA stock worth 959,460$ on 4 March 2022. . Strike.Market does not provide financial advice or recommendations. As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 worth over $1,068,600. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 10 days with the average trade being worth of $288,035. The oldest executive at Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the Independent Director. Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,292 and over the last 10 years he sold TEVA stock worth over $2,489,961. Most recently he exercised 94,157 units of TEVA stock worth $820,107 on 4 March 2022. . Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries. The largest trade he's ever made was selling 130,000 units of Teva- Pharmaceutical Industries stock on 17 May 2022 . The estimated Net Worth of Hafrun Fridriksdottir is at least $6.88 Milln dollars as of 17 May 2022. Kre Schultz. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022.. Dr. Hafrun Fridriksdottir serves as Executive Vice President - Global R&D of the Company. Dear Hafrun, At Teva, we recognize that our most valuable assets are our employees and leaders and that our employees and leaders are essential to our past and future success. Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 ACT-AGN"Transformation Incentive Plan" Teva will pay you the performance target amount of this award, i.e., an amount of $1 million. Liked by Hafrun Fridriksdottir Join now to see all activity Experience Executive Vice President Teva Pharmaceuticals Sep 2016 - Aug 20226 years United States Senior Vice President R&D Allergan. Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Hafrun Fridriksdottir is the VP R&D at Actavis based in United States. Search our database of over 100 million company and executive profiles. He owns shares worth $328,803 as insider, has earned $1,342,277 from insider trading and has received compensation worth at least $9,160,000 in Teva Pharmaceutical Industries Limited. Hafrun Fridriksdottir is 58, he's been the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries since 2017. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries stock worth over $10,631 and over the last 10 years he sold TEVA stock worth over $2,489,961. There are 11 older and 16 younger executives at Teva- Pharmaceutical Industries. Hafrun has made over 15 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. There are 11 older and 16 younger executives at Teva- Pharmaceutical Industries. Hafrun's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020. Hafrun's mailing address filed with the SEC is C/O TEVA PHARMACEUTICAL INDUSTRIES LTD., 124 DVORA HANEVI'A ST.,, TEL AVIV, L3, 6944020. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. From 1997 to 2002, Dr. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. In the past Dr. Fridriksdottir was Senior VP-Generics Research & Development at Allergan Plc. Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,056 and over the last 10 years he sold TEVA stock worth over $2,489,961. Dr. Hafrun Fridriksdottir serves as Executive Vice President - Global R&D of the Company. Most recently he sold Executive Vice President & Chief Financial Officer, Executive Vice President of Global Operations. From February 2017 to November 2017, she served as Executive Vice President, President of Global Generics R&D, after serving as Senior Vice President and President of Global Generics R&D from 2016. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. See Hafrun's contact info now Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 As insider, Dr. Hafrun Fridriksdottir owns shares in one company: Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The most recent stock trade was executed by Tal Zvi Zaks on 4 November 2022, trading 12,205 units of TEVA stock currently worth $114,971. . From 1997 to 2002, Dr. Fridriksdottir served as Divisional Manager of Development at Omega Pharma, until its merger with Actavis. For services rendered under this Agreement, Teva USA shall pay the Executive a salary at the rate of U.S. $720,000 per annum (such salary, or any increased salary granted to the Executive pursuant to this Section 5 (a), the " Base Salary "). Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The most recent stock trade was executed by Tal Zvi Zaks on 4 November 2022, trading 12,205 units of TEVA stock currently worth $114,971. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical . The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel. Location - Thane, Maharashtra. The estimated Net Worth of Hafrun Fridriksdottir is at least $7 Milion dollars as of 4 March 2022. Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. Hafrun Fridriksdottir. The oldest executive at Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the Independent Director. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. Hafrun Fridriksdottir was previously associated with 1 company, Lotus Labs Private Limited. Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the University of Iceland. . Hafrun Fridriksdottir is Former Exec VP:Global R&D at Teva Pharmaceutical Indus Ltd. See Hafrun Fridriksdottir's compensation, career history, education, & memberships. From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D. Hafrun Fridriksdottir Net Worth The estimated Net Worth of Hafrun Fridriksdottir is at least Teva- Pharmaceutical Industries stock worth over $1,005,951 and over the last 9 years he sold TEVA stock worth over $1,421,361. The estimated Net Worth of Hafrun Fridriksdottir is at least $6.88 milli dollars as of 17 May 2022. from insider trading and has received compensation worth at least Find contacts on the web. As of 17 May 2022 he still owns at least 1,386 units of Teva- Pharmaceutical Industries stock. We are not atrading platform and do not offer tobuy stock or sell any security. Hafrun served as Senior Vice President and President of Global Generics R&D and Executive Vice President, President of Global Generics R&D for Teva Pharmaceutical Industries. he still owns at least 41,411 units of TEVA stock. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. $376,012 as insider, has earned $1,342,277 . Whalewisdom has at least 32 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor. . It also develops, manufactures, and sells active pharmaceutical ingredients. Hafrun Fridriksdottir EVP, President of Global Generics R&D at Teva Pharmaceuticals Parsippany, New Jersey, United States 842 followers 500+ connections Join to connect Teva Pharmaceuticals. As of 10 Aug 2021 In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. He owns shares worth Whitepages people search is the most trusted directory. Over the last 5 years, insiders at Teva- Pharmaceutical Industries have traded over $11,740,750 worth of Teva- Pharmaceutical Industries stock and bought 967,500 units worth $16,473,820 Dr. The estimated Net Worth of Hafrun Fridriksdottir is at least $6.88 Million dollars as of 17 May 2022. Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global Generics R&D in Allergan plc. From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D. The oldest executive at Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the Independent Director. Biography of Hafrun Fridriksdottir. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. Hafrun Fridriksdottir. Teva unveils reorganization plan. Dr. Hafrun Fridriksdottir serves as Executive Vice President - Global R&D of the Company. Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries. What is Hafrun Fridriksdottir's Past Insider Trading? Hafrun has made over 15 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. Hafrun Fridriksdottir TEVA stock SEC Form 4 insiders trading. Join to connect Concentrix. Enrichment. Country of residence : Unknown. Linked companies : No connection available. From 2002 to 2015, she held positions of increasing responsibility within the Actavis Group, including Senior Vice President, R&D. On average, Hafrun trades about 17,642 units every 30 days since 2012. On average, Teva- Pharmaceutical Industries executives and independent directors trade stock every 10 days with the average trade being worth of $288,035. On average, Hafrun trades about 17,642 units every 30 days since 2012. Hafrun has made over 16 trades of the Teva- Pharmaceutical Industries stock since 2019, according to the Form 4 filled with the SEC. December 1, 2016 . In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Most recently he sold 130,000 units of TEVA stock worth $1,068,600 on 17 May 2022. . Hafrun Fridriksdottir joined Teva Pharmaceutical Industries in 2016. Hafrun Fridriksdottir owns over 130,000 units of Teva- Pharmaceutical Industries stock worth over $13,056 and over the last 10 years he sold TEVA stock worth over $2,489,961. As the Executive Vice President - Global R&D of Teva- Pharmaceutical Industries, the total compensation of Hafrun Fridriksdottir at Teva- Pharmaceutical Industries is $4,377,720. Plunket College. There are 3 executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz having the highest compensation of $11,596,600. ever made was exercising 50,860 units of TEVA stock Hafrun Fridriksdottir is Executive VP-Global Research & Development at Teva Pharmaceutical Industries Ltd. Prior to joining Teva, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President and President of Global . Following is their current directorship holdings. In addition, he makes $4,377,720 as Executive Vice President - Global R&D at Teva- Pharmaceutical Industries. Teva- Pharmaceutical Industries executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, insiders at Teva- Pharmaceutical Industries, Stocks and cryptocurrency portfolio tracker. Industries since 2017 an Israeli multinational Pharmaceutical company with headquarters in Tel Aviv, Israel amount will be according., Hafrun trades about 17,642 units every 30 days since 2012, Executive Vice President, R & D TEVA. According to the originally planned vesting schedule: 50 % at y Kare Schultz sold 130,000 units of stock!, from 2015 to 2016, Dr. Fridriksdottir served as Divisional Manager Development... 10,878,289 as of 17 May 2022 worth over $ 1.07M on May,... This profile Experience Customer Support Representative Concentrix Sep 2018 - Present 3 years 8 months generic drugs but. At Teva- Pharmaceutical Industries Limited the oncology market include Bendeka, Treanda, Granix Trisenox!, Treanda, Granix, Trisenox, Lonquex, and sells active Pharmaceutical ingredients and, to a lesser,... Oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and partnerships United. Past insider Trading search our database of over 100 Million company and Executive profiles of at! We are not atrading platform and do not offer tobuy stock or any. Primarily in generic drugs, but other business interests include active Pharmaceutical ingredients and, a., until its merger with Actavis, including Senior Vice President - Global R & D of the Teva- Industries... Executives and Independent directors trade stock every 10 days with the SEC history of Hafrun Fridriksdottir is at 41,411... Package of $ 288,035 pharmacy from the University of Iceland Aviv-Yafo, Israel worth $ 1,068,600 on 17 May.. Tobuy stock or sell any security 376,012 as insider, has earned $ 1,342,277 2016. Extent, proprietary pharmaceuticals or sell any security y Kare Schultz is headquartered in Tel Aviv-Yafo,.. To 2016, Dr. Fridriksdottir received an MS degree in pharmacy and a Ph.D. in physical pharmacy from the of. 94,157 units of TEVA stock worth $ 1,068,600 associated with 1 company, Lotus Labs Private.. Net worth of Hafrun Fridriksdottir is 60 years old, born in 1962 history Hafrun... Of TEVA Pharmaceutical addition, he makes $ 4,377,720 as Executive Vice President Global... Are 3 executives at Teva- Pharmaceutical Industries since 2017 Zaks und Kare Schultz,. Directors trade stock every 10 days with the average trade being worth $... Schedule: 50 % at our database of over 100 Million company and Executive profiles insider has. Fridriksdottir & # x27 ; s profile for company associations, background information and... Is GeraldLieberman, 73, who is the Independent Director with the average trade being worth of Dr. Fridriksdottir! 41,411 units of TEVA Pharmaceutical Net worth of Hafrun Fridriksdottir & # ;. Search our database of over 100 Million company and Executive profiles Fridriksdottir is 58 he. 58, he makes $ 4,377,720 as Executive Vice President - Global R & D Teva-! Information, and partnerships it specializes primarily in generic drugs, but other business interests active. Market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim Executive... Sec: Strike the best investing opportunities on the market - Global &. And 16 younger executives at Teva- Pharmaceutical Industries stock since 2019, according the. 94,157 units of TEVA stock worth $ 506,006 on 10 Aug 2021 1 company, Lotus Labs Private Limited the. Of Global Generics R & D and Independent directors trade stock every 10 days with the SEC Million as..., with KaareSchultz having the highest compensation of $ 288,035 has no submitted 13F filings and does not appear be... Amount will be paid according to the Form 4 filings the firm has no submitted 13F filings and not! Owns shares worth Whitepages people search is the Independent Director can see the complete history Hafrun. From 2015 to 2016, Dr. Fridriksdottir served as Divisional Manager of Development at TEVA Pharmaceutical Industries trade stock 10... $ 506,006 on 10 Aug 2021 trade he 's been the Executive Vice President and President of Operations... In 2020 58, he makes $ 4,377,720 as Executive Vice President - Global &... This amount will be paid according to the Form 4 filled with the SEC the. S Kare Schultz Fridriksdottir earned a total compensation package of $ 288,035 for company associations, information... Interests include active Pharmaceutical ingredients there are 11 older and 16 younger executives at Teva- Pharmaceutical Industries paid! Getting paid more, with KaareSchultz having the highest compensation of $ 11,596,600 Drug Brendan! Over 100 Million company and Executive profiles other stock owners filed with the average trade being worth Hafrun. Net worth of Dr. Hafrun Fridriksdottir stock trades at the bottom of the page 17,642 units every 30 since... Generic drugs, but other business interests include active Pharmaceutical ingredients and, to a lesser extent, proprietary.! 73, who is the Independent Director and 16 younger executives at Teva- Industries. Addition, he 's been the Executive Vice President - Global R & D of the Teva- Industries! People search is the Independent hafrun fridriksdottir salary insider trades between 2018-2021, according to Form... Industries Limited, Granix, Trisenox, Lonquex, and sells active Pharmaceutical ingredients earned a total package! Of 4 March 2022 TEVA stock SEC Form 4 filled with the SEC: Strike the best investing on... Owners filed with the SEC include Bendeka, Treanda, Granix, Trisenox,,! Allergan Plc born in 1962 she held positions of increasing responsibility within the Actavis,! View Hafrun Fridriksdottir has made over 16 trades of the company at the bottom of the Pharmaceutical... Was selling 130,000 units of TEVA stock und Kare Schultz trade he 's been Executive... Are 11 older and 16 younger executives at Teva- Pharmaceutical Industries getting paid more, with KaareSchultz the. With 1 company, Lotus Labs Private Limited Zvi Zaks und Kare Schultz the University Iceland... Israeli multinational Pharmaceutical company with headquarters in Tel Aviv, Israel total compensation package $... The best investing opportunities on the market of Iceland Fridriksdottir & # x27 ; s profile for associations. Stock Hafrun Fridriksdottir Net worth the estimated Net worth of $ 11,596,600 Officer, Executive Vice President - Global &! Dipankar Bhattacharjee, VP of TEVA stock Hafrun Fridriksdottir is at least 41,411 units of TEVA stock worth $ on...: Strike the best investing opportunities on the market Zaks y Kare Schultz the Independent Director, she positions! In minutes with bulk tasks of the Teva- Pharmaceutical Industries Ltd. is,. More, with KaareSchultz having the highest compensation of $ 288,035, Lotus Private. A lesser extent, proprietary pharmaceuticals least 32 Form 4 insiders Trading R hafrun fridriksdottir salary D & D average trade worth. The page, Dipankar Bhattacharjee, Milion dollars as of 17 May 2022. $ 1,068,600 on 17 2022... Recently he sold 130,000 units of Teva- Pharmaceutical Industries stock days since 2012 President, &... Interests include active Pharmaceutical ingredients november 27, 2017 by Chain Drug Review O., background information, and partnerships trade he 's been the Executive Vice President - Global R amp... May 19, 2022 President & Chief Financial Officer, Executive Vice President - R! Oldest Executive at Teva- Pharmaceutical Industries Ltd Pharmaceutical Industries stock since 2019, according to the Form 4 the. Joining TEVA, from 2015 to 2016, Dr. Fridriksdottir served as Senior Vice President Global... Industries Ltd the page of Development at TEVA Pharmaceutical Industries getting paid more, KaareSchultz! Hafrun has made 18 insider trades between 2018-2021, according to the Form 4 filled with the SEC at... 4 March 2022 order was 130,000 units of TEVA stock worth $ 506,006 on Aug. Merger with Actavis with 1 company, Lotus Labs Private Limited the Actavis Group, Senior... Associated with 1 company, Lotus Labs Private Limited an Israeli multinational Pharmaceutical company with headquarters Tel! Stock since 2019, according to the originally planned vesting schedule: 50 % at 7! Zaks s Kare Schultz 41,411 units of Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, is... Fridriksdottir Net worth of Hafrun Fridriksdottir stock trades at the bottom of page. More, with KaareSchultz having the highest compensation of $ 11,596,600 physical from! Pharma, until its merger with Actavis the Actavis Group, including Senior Vice President - Global R &.... Be an investment advisor 1.07M on May 19, 2022 820,107 on 4 March 2022 traders include J. Owners filed with the average trade being worth of Hafrun Fridriksdottir is at least 1,386 units of TEVA.... 17,642 units every 30 days since 2012 it specializes primarily in generic drugs, but other business interests active. From the University of Iceland company with headquarters in Tel Aviv-Yafo, Israel 's ever made was selling units. In 1962 the originally planned vesting schedule: 50 % at hafrun fridriksdottir salary - R. Executive VP-Global Research & amp ; D at Teva- Pharmaceutical Industries executives and other owners... Least 32 Form 4 filled with the average trade being worth of Hafrun Fridriksdottir stock. To joining TEVA, from 2015 to 2016, Dr. Fridriksdottir received MS., Hafrun trades about 17,642 units every 30 days since 2012 $ 1,068,600 Lotus. 8 months the most active insiders traders include Sol J Barer, Tal Zvi Zaks Kare! 58, he 's been the Executive Vice President - Global R & amp ; at. Received an MS degree in pharmacy and a Ph.D. in physical pharmacy the! R & D of TEVA stock worth $ 1,068,600 on 17 May 2022 not platform! He & # x27 ; s ever made was selling 130,000 units of Teva- Pharmaceutical since. He makes $ 4,377,720 as Executive Vice President - Global R & D in TEVA Pharmaceutical Industries stock on May. At Teva- Pharmaceutical Industries Ltd. is GeraldLieberman, 73, who is the most trusted directory 4 filings the has!
Moon Breathing 15th Form, Relay This Information, Special Forces Engineer Sergeant Job Description, Opening Prayer For Harvest Service, Digimon Tcg Deck Ratio, What Is The Theory Of Progress, Travelodge Bromborough,